RxDoctor Payments Data

Shannon Dunlap, APRN

Family · Olanta, SCNPI 1285231845

Payments from drug & device makers

$814in general payments, 2019–2025

Across 48 payments — averaging $16.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$166
  • Amgen$150
  • Novartis$138
  • Novo Nordisk$127
  • Insulet Corporation$72
  • Bayer$56
  • plus $106 from 5 others

What the payments were for

  • Food & beverage$814100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$814 in reported general payments places this provider in the 60th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$28,754
Medicare patients
167
Services billed
459

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide54$82,212
OzempicSemaglutide38$81,617
FarxigaDapagliflozin Propanediol49$74,702
Repatha SureclickEvolocumab63$69,643
EliquisApixaban61$69,355
LipitorAtorvastatin Calcium46$67,367
Trelegy ElliptaFluticasone/Umeclidin/Vilanter42$58,320
ProtonixPantoprazole Sodium43$50,965
LinzessLinaclotide34$48,671
JardianceEmpagliflozin28$42,810
NorvascAmlodipine Besylate52$42,347
NeurontinGabapentin28$41,494
VascepaIcosapent Ethyl45$36,000
CrestorRosuvastatin Calcium44$34,295
JanuviaSitagliptin Phosphate27$31,713

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$127$109,14249 claims
Lilly USA, LLCMounjaro$14$82,21254 claims
MerckJanuvia$14$31,71327 claims
NovartisDiovan$138$15,62115 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,248 family providers in South Carolina.

Other family in Olanta

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →